Page 38 - ebook
P. 38

[B. Cell Biology/Stem Cell] B-19




                 Differentiation of Various Gastric Cancer Cell Lines using


                                  Glycome Signatures by LC-MS/MS





                               Jihyeon Nam¹,², Nari Seo¹,², J Eugene Lee³, Hyun Joo An¹,²*

          ¹Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon 34134, Korea,

             ²Asia-Pacific Glycomics Reference Site, Chungnam National University, Daejeon 34134, Korea, ³Center for

                      Bioanalysis, Korea Research Institute of Standards and Science, Daejeon 34113, Korea





        Glycosylation, which is highly sensitive to the external environment, has been considered as a window reflecting
        physiological state of cell. Since abnormal glycans are a hallmark of diseases, the characterization of glycans is

        gaining attention in biomarker research for treatment and diagnosis. In particular, gastric cancer (GC) with various
        subtypes has highly different clinical results for each patient. Although gastric cancer patients are classified into

        different subgroups according to genetic profiling and clinical symptoms, targeted treatment is difficult. In this study,
        we have characterized the glycans obtained from representative GC cell. In order to selectively separate the glycans

        located on the cell  surface, the  cell membrane  extraction  was  first performed.  Subsequently, glycans  were
        enzymatically released, enriched, and profiled via PGC nanoLC/MS and LC/MS/MS. Using normalized glycan intensity,

        a correlation among GC cell lines was examined through hierarchical analysis. The heterogeneity of each cell line
        was distinguished by moietise of glycans such as fucosylation, sialylation, LacdiNAc and bisecting structures. Our

        findings on GC cell line-specific glycans may pave the way for accurate diagnosis of heterogeneous gastric cancer
        and the potential for molecular target recognition for gastric cancer treatment.
   33   34   35   36   37   38   39   40   41   42   43